glp-1 diabetes news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD Medical professionals share risks of

Although strict glycemic control has beneficial effects on microvascular complications (retinopathy, nephropathy or neuropathy), it does not seem to reduce the risk of cardiovascular disease, and it is associated with an increased risk of hypoglycemia in patients with DM2.3,6 Until recently, the antihyperglycemic drugs available have improved glycemic control, but without much benefits on cardiovascular and/or renal risk

In addition, when co-cultured with human breast cancer cells, neutrophils produced high levels of oncostatin M (OSM) (84), which was shown to act on the endothelium via STAT-3/VEGF signaling in vivo and to enable the remodeling of the TME by activating cancer-associated fibroblasts (CAF) (85, 86)

A prospective study of the association between physical activity and risk of prostate cancer defined by clinical features and TMPRSS2:ERG

Notably, this suggests the drug enhances the mechanisms that signal fullness, rather than suppressing hunger

N cung cp 2 in tch m v 1 in tch dng cho cc gc t do thiu in tch tng ng, t h tr ngn chn s sn sinh hng lot ca cc gc t do